Company intelligence / Profile preview

BioVeda China

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

BVCF Management, formerly known as BioVeda China Fund, is a leading private equity and venture capital firm specializing in the China healthcare and life sciences sectors. Founded in 2005 by Dr. Zhi Yang, it was one of the first China-focused healthcare investment funds. The firm invests across various stages, from early-stage venture to growth capital, targeting sectors such as biopharmaceuticals, medical devices, and healthcare services. BVCF leverages its deep industry expertise and extensive network to support companies in navigating the Chinese regulatory and market landscape. The firm has a strong track record of identifying and nurturing high-growth companies that address significant unmet medical needs in China and globally.

Industry: Investors

Beyond the preview

Go deeper on BioVeda China.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioVeda China.

Explore the full profile